July 2020
Earle A. Chiles Research Institute, a division of Providence Cancer Institute in the Robert W. Franz Cancer Center, is currently conducting more than 130 research studies, including clinical trials of targeted therapies and novel immunotherapy approaches.
New phase I immuno-oncology study for
HPV16+ cancers
Image credit: UCSF Health
An unmet clinical need exists for patients with cancers associated with human papillomavirus. A new phase I study at Providence Cancer Institute will evaluate a novel biologic therapy in patients with recurrent, locally advanced or metastatic human papillomavirus strain 16 positive (HPV16+) solid tumors:

SQZ-PBMC-HPV as Monotherapy and in Combination with Atezolizumab in HPV16+ Solid Tumors

All current open studies:
Find additional studies for many types of cancer in Multiple Tumor Types .
New studies are posted frequently - please check our  website  for a complete list of our current studies. For more information, call 503-215-2614.